Adalimumab BS subcutaneous injection 40mg syringe 0.4mL “MA”, manufactured by Mochida Pharmaceutical, contains Adalimumab (genetical recombination) [Adalimumab follow-on 3]. Adalimumab is a TNF inhibitor used to treat autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. It is available as a 40mg/0.4mL/1 tube injectable drug (YJ code: 3999463G2021).
Adalimumab BS subcutaneous injection 40mg syringe 0.4mL “MA”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →